These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Substrate specificity of serum DNA- and RNA-hydrolyzing antibodies of patients with polyarthritis and autoimmune thyroiditis]. Vlasov AV; Baranovskiĭ AG; Kanyshkova TG; Prints AV; Zabara VG; Naumov VA; Breusov AA; Giege R; Buneva VN; Nevinskiĭ GA Mol Biol (Mosk); 1998; 32(3):559-69. PubMed ID: 9720080 [No Abstract] [Full Text] [Related]
5. [Phenomenon of DNA-abzyme cross-reactivity and its significance for the mechanisms of cytotoxicity and apoptosis]. Suchkov SV; Gabibov AG; Gnuchev NV Ontogenez; 2001; 32(5):348-52. PubMed ID: 11605407 [TBL] [Abstract][Full Text] [Related]
6. [Achievements and prospects of clinical abzymology]. Suchkov SV; Alekberova ZS; Paleev FN; Naumova TE; Misikov VK; Kriazheva ES; Ponomarenko NA; Gabivov AG Vestn Ross Akad Med Nauk; 2005; (9):38-43. PubMed ID: 16250330 [TBL] [Abstract][Full Text] [Related]
7. [Interaction of catalytically active antibodies with oligoribonucleotides]. Buneva VN; Andrievskaia OA; Romannikova IV; Gololobov GV; Iadav RP; Iamkovoĭ VI; Nevinskiĭ GA Mol Biol (Mosk); 1994; 28(4):738-43. PubMed ID: 7990801 [TBL] [Abstract][Full Text] [Related]
8. Evolution of biomarker research in autoimmunity conditions for health professionals and clinical practice. Silverstein A; Dudaev A; Studneva M; Aitken J; Blokh S; Miller AD; Tanasova S; Rose N; Ryals J; Borchers C; Nordstrom A; Moiseyakh M; Herrera AS; Skomorohov N; Marshall T; Wu A; Cheng RH; Syzko K; Cotter PD; Podzyuban M; Thilly W; Smith PD; Barach P; Bouri K; Schoenfeld Y; Matsuura E; Medvedeva V; Shmulevich I; Cheng L; Seegers P; Khotskaya Y; Flaherty K; Dooley S; Sorenson EJ; Ross M; Suchkov S Prog Mol Biol Transl Sci; 2022; 190(1):219-276. PubMed ID: 36008000 [TBL] [Abstract][Full Text] [Related]
9. DNA-hydrolyzing Ab: is catalytic activity a clue for physiological significance? Kozyr AV; Gabibov AG Autoimmunity; 2009 May; 42(4):359-61. PubMed ID: 19811301 [TBL] [Abstract][Full Text] [Related]
10. Catalytic antibodies in clinical and experimental pathology: human and mouse models. Ponomarenko NA; Durova OM; Vorobiev II; Aleksandrova ES; Telegin GB; Chamborant OG; Sidorik LL; Suchkov SV; Alekberova ZS; Gnuchev NV; Gabibov AG J Immunol Methods; 2002 Nov; 269(1-2):197-211. PubMed ID: 12379362 [TBL] [Abstract][Full Text] [Related]
12. Physiopathology of natural auto-antibodies: the case for regulation. Zelenay S; Moraes Fontes MF; Fesel C; Demengeot J; Coutinho A J Autoimmun; 2007 Dec; 29(4):229-35. PubMed ID: 17967665 [TBL] [Abstract][Full Text] [Related]
13. The association between EAE development in mice and the production of autoantibodies and abzymes after immunization of mice with different antigens. Aulova KS; Urusov AA; Sedykh SE; Toporkova LB; Lopatnikova JA; Buneva VN; Sennikov SV; Budde T; Meuth SG; Popova NA; Orlovskaya IA; Nevinsky GA J Cell Mol Med; 2021 Mar; 25(5):2493-2504. PubMed ID: 33560578 [TBL] [Abstract][Full Text] [Related]